{'fraction_non_alphanumeric': 0.02142857142857143, 'fraction_numerical': 0.017857142857142856, 'mean_word_length': 5.303370786516854, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
The World Congress on Treatment and Research in Multiple Sclerosis (joint meeting of ECTRIMS, ACTRIMS, LACTRIMS).

This congress was the first joint meeting for European, North and South American neurologists and neuroscientists to discuss 1 year of progress in treatment and research on multiple sclerosis (MS). More than 4500 delegates attended and with 83 oral presentations and 909 posters, it is difficult to select the highlights from this large amount of information. Probably the most interesting topic for neurologists and patients was new treatments.